Braxia Scientific Corp.
BRAXF · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $492 | $594 | $600 | $522 |
| % Growth | -17.1% | -1% | 14.9% | – |
| Cost of Goods Sold | $410 | $590 | $734 | $1,528 |
| Gross Profit | $82 | $5 | -$133 | -$1,005 |
| % Margin | 16.6% | 0.8% | -22.2% | -192.4% |
| R&D Expenses | $0 | $9 | $19 | $1 |
| G&A Expenses | $625 | $180 | $448 | $1,778 |
| SG&A Expenses | $640 | $197 | $469 | $1,817 |
| Sales & Mktg Exp. | $15 | $17 | $21 | $39 |
| Other Operating Expenses | $420 | $0 | $0 | $0 |
| Operating Expenses | $1,059 | $264 | $656 | $1,284 |
| Operating Income | -$977 | -$260 | -$790 | -$2,289 |
| % Margin | -198.4% | -43.7% | -131.5% | -438.1% |
| Other Income/Exp. Net | $70 | $129 | $84 | -$5,627 |
| Pre-Tax Income | -$907 | -$269 | -$798 | -$7,791 |
| Tax Expense | $0 | $3 | $4 | -$146 |
| Net Income | -$907 | -$273 | -$802 | -$7,658 |
| % Margin | -184.2% | -45.9% | -133.7% | -1,465.8% |
| EPS | -0.003 | -0.001 | -0.003 | -0.029 |
| % Growth | -240% | 66.7% | 89.7% | – |
| EPS Diluted | -0.003 | -0.001 | -0.003 | -0.029 |
| Weighted Avg Shares Out | 263,754 | 263,709 | 263,709 | 263,709 |
| Weighted Avg Shares Out Dil | 263,709 | 263,709 | 263,709 | 263,709 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $26 | $26 | $4 | $3 |
| Depreciation & Amortization | $74 | $73 | $56 | $162 |
| EBITDA | -$808 | -$174 | -$742 | -$2,127 |
| % Margin | -164% | -29.2% | -123.6% | -407.1% |